DMC Group LLC Has $405,000 Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

DMC Group LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 8.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,014 shares of the biotechnology company’s stock after purchasing an additional 79 shares during the period. DMC Group LLC’s holdings in Axon Enterprise were worth $405,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of AXON. Quent Capital LLC lifted its holdings in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Blue Trust Inc. lifted its stake in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise in the first quarter valued at approximately $31,000. First PREMIER Bank bought a new stake in Axon Enterprise in the first quarter worth approximately $33,000. Finally, Friedenthal Financial acquired a new position in shares of Axon Enterprise during the 3rd quarter worth $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the sale, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now owns 4,892 shares of the company’s stock, valued at $1,783,916.72. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 371,172 shares of company stock worth $137,000,162 in the last 90 days. 5.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Jefferies Financial Group started coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective for the company. Robert W. Baird boosted their price target on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Needham & Company LLC restated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Northland Securities increased their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Finally, Bank of America assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $365.38.

Axon Enterprise Stock Up 0.8 %

Shares of AXON stock opened at $438.05 on Friday. The stock has a market cap of $33.10 billion, a P/E ratio of 115.58, a price-to-earnings-growth ratio of 11.74 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. The stock has a fifty day moving average price of $388.71 and a 200 day moving average price of $331.79. Axon Enterprise, Inc. has a one year low of $199.29 and a one year high of $440.89.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.80 earnings per share. Analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.